MedPath

HCP1302

Generic Name
HCP1302

Trial to Evaluate the Efficacy and Safety of HCP1302

Phase 3
Completed
Conditions
Erectile Dysfunction
Hypertension
Interventions
Drug: Placebo (for HCP1302)
Drug: Placebo (for HGP0904)
First Posted Date
2015-10-27
Last Posted Date
2016-11-01
Lead Sponsor
Hanmi Pharmaceutical Company Limited
Target Recruit Count
232
Registration Number
NCT02587988
© Copyright 2025. All Rights Reserved by MedPath